Belite Bio, Inc Share Price
NASDAQ: BLTEBelite Bio, Inc Stock Performance
Belite Bio, Inc Share Price Today
As of 30 October 2026, Belite Bio, Inc's share price is $148.44. The stock opened at $150.49, compared to its previous close of $146.72. During today's trading session, Belite Bio, Inc's share price traded between $149.07 and $150.49, with an average price of $149.78. Over the past 52 weeks, the stock has recorded a high of $199.70 and a low of $94.51. In terms of performance, Belite Bio, Inc's share price has declined by 6.77% over the last six months and is up 40.55% on a year-on-year basis.
Belite Bio, Inc Share Price Chart
Belite Bio, Inc Annual Profit & Loss
All figures in USD
About Belite Bio, Inc
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Belite Bio, Inc Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $169.83 | $149.07 | -12.73% |
Sep 2026 | $154.37 | $170.82 | +8.74% |
Aug 2026 | $155.00 | $157.09 | -1.11% |
Jul 2026 | $155.56 | $158.86 | +3.22% |
Jun 2026 | $136.70 | $153.90 | +6.75% |
May 2026 | $157.75 | $144.16 | -9.46% |
Apr 2026 | $164.25 | $159.22 | -0.15% |
Mar 2026 | $178.00 | $159.46 | -16.43% |
Feb 2026 | $169.31 | $190.80 | +13.07% |
Jan 2026 | $160.00 | $168.74 | +5.83% |
Dec 2025 | $154.00 | $159.44 | +15.84% |
Nov 2025 | $114.00 | $137.64 | +30.33% |